Drug Profile
Research programme: siRNA therapeutics - IC-Vec
Latest Information Update: 04 Mar 2008
Price :
$50
*
At a glance
- Originator IC-Vec
- Class Small interfering RNA
- Mechanism of Action RNA inhibitors; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Hepatitis B; Hepatitis C
Most Recent Events
- 01 Dec 2005 Preclinical trials in Cancer in United Kingdom (unspecified route)
- 09 Sep 2005 Preclinical trials in Hepatitis B in United Kingdom (unspecified route)
- 09 Sep 2005 Preclinical trials in Hepatitis C in United Kingdom (unspecified route)